205 related articles for article (PubMed ID: 23601761)
1. International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer.
Lin NU; Thomssen C; Cardoso F; Cameron D; Cufer T; Fallowfield L; Francis PA; Kyriakides S; Pagani O; Senkus E; Costa A; Winer EP;
Breast; 2013 Jun; 22(3):203-10. PubMed ID: 23601761
[TBL] [Abstract][Full Text] [Related]
2. International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?
Pagani O; Senkus E; Wood W; Colleoni M; Cufer T; Kyriakides S; Costa A; Winer EP; Cardoso F;
J Natl Cancer Inst; 2010 Apr; 102(7):456-63. PubMed ID: 20220104
[TBL] [Abstract][Full Text] [Related]
3. Promoting quality and evidence-based care in early-stage breast cancer follow-up.
Henry NL; Hayes DF; Ramsey SD; Hortobagyi GN; Barlow WE; Gralow JR
J Natl Cancer Inst; 2014 Apr; 106(4):dju034. PubMed ID: 24627271
[TBL] [Abstract][Full Text] [Related]
4. Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care?
Hahn EE; Tang T; Lee JS; Munoz-Plaza CE; Shen E; Rowley B; Maeda JL; Mosen DM; Ruckdeschel JC; Gould MK
Cancer; 2016 Mar; 122(6):908-16. PubMed ID: 26650715
[TBL] [Abstract][Full Text] [Related]
5. First-line chemotherapy for metastatic breast cancer.
Telli ML; Carlson RW
Clin Breast Cancer; 2009 Jun; 9 Suppl 2():S66-72. PubMed ID: 19596645
[TBL] [Abstract][Full Text] [Related]
6. Imaging in the evaluation and follow-up of early and advanced breast cancer: When, why, and how often?
Bychkovsky BL; Lin NU
Breast; 2017 Feb; 31():318-324. PubMed ID: 27422453
[TBL] [Abstract][Full Text] [Related]
7. Preventive health care, 1999 update: 3. Follow-up after breast cancer. Canadian Task Force on Preventive Health Care.
Temple LK; Wang EE; McLeod RS
CMAJ; 1999 Oct; 161(8):1001-8. PubMed ID: 10551200
[TBL] [Abstract][Full Text] [Related]
8. Future treatment strategies for metastatic breast cancer: curable or incurable?
Iwata H
Breast Cancer; 2012 Jul; 19(3):200-5. PubMed ID: 21491123
[TBL] [Abstract][Full Text] [Related]
9. Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey.
Bonotto M; Basile D; Gerratana L; Pelizzari G; Bartoletti M; Vitale MG; Fanotto V; Lisanti C; Mansutti M; Minisini AM; Aprile G; De Laurentiis M; Montemurro F; Del Mastro L; Puglisi F
Breast; 2018 Aug; 40():45-52. PubMed ID: 29679936
[TBL] [Abstract][Full Text] [Related]
10. Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients.
Harbeck N; Schmitt M; Meisner C; Friedel C; Untch M; Schmidt M; Sweep CG; Lisboa BW; Lux MP; Beck T; Hasmüller S; Kiechle M; Jänicke F; Thomssen C;
Eur J Cancer; 2013 May; 49(8):1825-35. PubMed ID: 23490655
[TBL] [Abstract][Full Text] [Related]
11. AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer.
Gianni L; Romieu GH; Lichinitser M; Serrano SV; Mansutti M; Pivot X; Mariani P; Andre F; Chan A; Lipatov O; Chan S; Wardley A; Greil R; Moore N; Prot S; Pallaud C; Semiglazov V
J Clin Oncol; 2013 May; 31(14):1719-25. PubMed ID: 23569311
[TBL] [Abstract][Full Text] [Related]
12. Metastatic breast cancer in young women: a population-based cohort study to describe risk and prognosis.
Tjokrowidjaja A; Lee CK; Houssami N; Lord S
Intern Med J; 2014 Aug; 44(8):764-70. PubMed ID: 24863750
[TBL] [Abstract][Full Text] [Related]
13. Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive Metastatic Breast Cancer Previously Treated With Chemotherapy and 2 or More HER2-Targeted Agents: Results From the T-PAS Expanded Access Study.
Yardley DA; Krop IE; LoRusso PM; Mayer M; Barnett B; Yoo B; Perez EA
Cancer J; 2015; 21(5):357-64. PubMed ID: 26389758
[TBL] [Abstract][Full Text] [Related]
14. Plasma S100P level as a novel prognostic marker of metastatic breast cancer.
Peng C; Chen H; Wallwiener M; Modugno C; Cuk K; Madhavan D; Trumpp A; Heil J; Marmé F; Nees J; Riethdorf S; Schott S; Sohn C; Pantel K; Schneeweiss A; Yang R; Burwinkel B
Breast Cancer Res Treat; 2016 Jun; 157(2):329-338. PubMed ID: 27146585
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumor cells in patients with breast cancer: monitoring chemotherapy success.
Ušiaková Z; Mikulová V; Pintérová D; Brychta M; Valchář J; Kubecová M; Tesařová P; Bobek V; Kološtová K
In Vivo; 2014; 28(4):605-14. PubMed ID: 24982230
[TBL] [Abstract][Full Text] [Related]
16. miRNA profile obtained by next‑generation sequencing in metastatic breast cancer patients is able to predict the response to systemic treatments.
Martinez-Gutierrez AD; Catalan OM; Vázquez-Romo R; Porras Reyes FI; Alvarado-Miranda A; Lara Medina F; Bargallo-Rocha JE; Orozco Moreno LT; Cantú De León D; Herrera LA; López-Camarillo C; Pérez-Plasencia C; Campos-Parra AD
Int J Mol Med; 2019 Oct; 44(4):1267-1280. PubMed ID: 31364724
[TBL] [Abstract][Full Text] [Related]
17. Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review.
Kobayashi T; Ichiba T; Sakuyama T; Arakawa Y; Nagasaki E; Aiba K; Nogi H; Kawase K; Takeyama H; Toriumi Y; Uchida K; Kobayashi M; Kanehira C; Suzuki M; Ando N; Natori K; Kuraishi Y
Breast Cancer; 2012 Jul; 19(3):218-37. PubMed ID: 22532161
[TBL] [Abstract][Full Text] [Related]
18. Postoperative follow-up of patients with early breast cancer: reappraisal of serum tumor markers.
Anan K; Mitsuyama S; Tamae K; Suehara N; Nishihara K; Ogawa Y; Iwashita T; Abe Y; Ihara T; Nakahara S; Katsumoto F; Toyoshima S
Surg Today; 2002; 32(1):13-8. PubMed ID: 11871811
[TBL] [Abstract][Full Text] [Related]
19. High-dose estrogen as salvage hormonal therapy for highly refractory metastatic breast cancer: a retrospective chart review.
Mahtani RL; Stein A; Vogel CL
Clin Ther; 2009; 31 Pt 2():2371-8. PubMed ID: 20110046
[TBL] [Abstract][Full Text] [Related]
20. Maintenance treatment in metastatic breast cancer.
Sánchez-Muñoz A; Pérez-Ruiz E; Ribelles N; Márquez A; Alba E
Expert Rev Anticancer Ther; 2008 Dec; 8(12):1907-12. PubMed ID: 19046111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
